|
US 12,213,968 B2 |
|
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea |
Michael D. Kaufman, Waltham, MA (US); Scott Bone, Bend, OR (US); Corey Bloom, Bend, OR (US); and Fred Jordan, Bend, OR (US) |
Assigned to Deciphera Pharmaceuticals, LLC, Waltham, MA (US) |
Filed by Deciphera Pharmaceuticals, LLC, Waltham, MA (US) |
Filed on Aug. 6, 2024, as Appl. No. 18/795,731. |
Application 18/795,731 is a continuation of application No. 18/758,007, filed on Jun. 28, 2024. |
Application 18/758,007 is a continuation of application No. 18/518,093, filed on Nov. 22, 2023, granted, now 12,064,422. |
Application 18/518,093 is a continuation of application No. 18/448,312, filed on Aug. 11, 2023, granted, now 11,903,933, issued on Feb. 20, 2024. |
Application 18/448,312 is a continuation of application No. 18/178,789, filed on Mar. 6, 2023, granted, now 11,793,795, issued on Oct. 24, 2023. |
Application 18/178,789 is a continuation of application No. 18/148,766, filed on Dec. 30, 2022, granted, now 11,896,585, issued on Feb. 13, 2024. |
Application 18/148,766 is a continuation of application No. 17/735,820, filed on May 3, 2022, granted, now 11,612,591, issued on Mar. 28, 2023. |
Application 17/735,820 is a continuation of application No. 17/180,241, filed on Feb. 19, 2021, granted, now 11,395,818, issued on Jul. 26, 2022. |
Application 17/180,241 is a continuation of application No. PCT/US2020/067560, filed on Dec. 30, 2020. |
Claims priority of provisional application 62/968,695, filed on Jan. 31, 2020. |
Claims priority of provisional application 62/968,724, filed on Jan. 31, 2020. |
Claims priority of provisional application 62/955,062, filed on Dec. 30, 2019. |
Claims priority of provisional application 62/955,073, filed on Dec. 30, 2019. |
Prior Publication US 2024/0390345 A1, Nov. 28, 2024 |
This patent is subject to a terminal disclaimer. |
Int. Cl. A61K 31/4375 (2006.01); A61K 9/00 (2006.01); A61K 9/10 (2006.01); A61K 47/38 (2006.01) |